x
Elara Pharmaceuticals Ltd - Logo
[contact-form-7 404 "Not Found"]

  • The Barn Holly Berry House Rough Park,
    Hamstall Ridware, Rugeley, Staffordshire, WS15 3SQ
  • 666-888-0000
  • info@elarapharma.com
Elara Pharmaceuticals Ltd - Logo
  • info@elarapharma.com
  • The Barn Holly Berry House Rough Park,
    Hamstall Ridware, Rugeley, Staffordshire, WS15 3SQ
  • Contact Us
  • Home
  • About Us
  • Our Business
  • Our Technology
  • Real World Data
  • News
    • In The News
    • Publications
  • Careers
Logo

Contact Info

  • The Barn Holly Berry House Rough Park,
    Hamstall Ridware, Rugeley, Staffordshire, WS15 3SQ
  • +44 20 8040 0302
  • info@elarapharma.com

Tag: cancer

Cancer

Nov2016

Tersan to present on Combination Therapy in Melanoma with Harvard Medical School (Paris | Nov 29 – Dec 2nd)

Dr Parmentier will present a poster “Combination Therapy in Melanoma: finding biomarkers of synergistic associations using Large Scale Drug Combination Screening and integrated Omics Data Analysis” at the Institut Pasteur International Network Scientific Symposium in Paris on November 30th.   The poster showcases the results of a collaborative study between Tersan and the Massachusetts General […]

Read More
Cancer

Sep2016

Elara Pharmaceuticals Ltd (Paris, Boston) and ValiSeek (London) to collaborate on Phase II Non-small Cell Lung Cancer treatment

Tersan’s advanced data analytics, using its KEM® decision support platform, will help ValiSeek boost success outlook. Tersan® Pharma, a leading digital health Company focused on developing advanced personalized therapeutic decision support systems and a provider of decision support tools and services to accelerate drug development, announces today that it has won a significant contract of […]

Read More
Cancer

Jun2016

WIN 2016 Symposium (Paris | June 27-28)

The WIN 2016 Symposium is the place to be to learn about the latest in cancer research by world class presenters. Come and meet the Tersan team of Dr Mohammad Afshar, Dr Guergova-Kuras, Dr Morley and Dr Vaucouleur.

Read More
Cancer

Jun2015

WIN 2015 Symposium (Paris | 29-30 June)

Dr Mohammad Afshar (Founder and CEO) is presenting our Onco KEM® platform at WIN 2015 on 29 June. Dr. Mariana Guergova-Kuras (CTO) and Dr David Morley (VP Computational Technology) will also be attending the symposium for a fascinating two days of cutting-edge presentations and discussions with global key opinion leaders in cancer research and precision cancer […]

Read More
Cancer

Jun2015

Tersan® Pharma teams together with SIB Swiss Institute of Bioinformatics to discover novel biomarkers for gastric cancer

Leader in clinical big data analytics collaborates with world-class bioinformatics provider in GastricGlycoExplorer consortiumPartnership to develop early detection tools for one of the deadliest cancers Links: Download English PDF | Download French PDF Paris, France, Cambridge, Massachusetts USA, and Geneva, Switzerland, 1 June 2015 – Elara Pharmaceuticals Ltd, developer of innovative clinical data analysis and diagnostic […]

Read More
Cancer

Jan2015

Nabsys and Elara Pharmaceuticals Ltd Collaborate to Identify DNA Structural Variants Linked to Targeted Cancers

Nabsys will collaborate with Elara Pharmaceuticals Ltd to identify structural variations related to breast and prostate cancer and how they affect clinical outcome of patients. Links: Download English PDF Providence, Rhode Island, USA, and Paris, FRANCE – January 12th , 2015 – Nabsys, Inc., a life sciences company pioneering semiconductor-based tools for human genomic analysis in […]

Read More
Cancer

Dec2014

Onco KEM(R) platform for personalized cancer treatment selection

Elara Pharmaceuticals Ltd releases a video to illustrate its innovative Onco KEM® platform for personalized cancer treatment selection. Onco KEM® intends to accelerate the translation of personalized medicine discoveries into widely available new standards of care for all cancer patients, leading to significantly improved clinical outcomes and a higher quality of life for cancer patients.   […]

Read More
Cancer

Oct2014

Elara Pharmaceuticals Ltd joins the WIN Consortium as official technology partner

Leader in clinical big data analytics collaborates with global stakeholders in personalized cancer medicine. Partnership to accelerate translation of personalized medicine discoveries into widely available new standards of care for all cancer patients. Links: Download English PDF | Download French PDF Paris, France, and Cambridge, Massachusetts USA, 29 October 2014 – Elara Pharmaceuticals Ltd, developer of […]

Read More
Cancer

Jul2014

Presentations from WIN 2014 Symposium (Paris | June 23 – 24)

Young researchers from Elara Pharmaceuticals Ltd presented two posters at the recent WIN 2014 Symposium on breakthrough biomarker investigations and combined therapeutic approaches for precision cancer medicine, held in Paris on 23-24 June 2014. “P2.26: Computational biomarker models to predict response to lung cancer treatments from combined molecular data”, Marine Le Morvan, Maria del Pilar Schneider, […]

Read More
Cancer

Feb2014

Effective Design of Multi-Marker Diagnostic Tests for Personalized Medicine

Elara Pharmaceuticals Ltd releases a video to illustrate the use of its KEM® data mining technology in the effective design of multi-marker diagnostic tests for personalized medicine; KEM® identifies the shortest and most accurate signatures. The video is available on our Vimeo and YouTube channels or can be viewed below.   One size doesn’t fit all! […]

Read More

Posts navigation

1 2 3

Categories

  • Alzheimer's
  • Autism
  • Autoimmune disease
  • Cancer
  • Fibromyalgia
  • Kidney Transplant
  • Parkinson’s
  • Precision Medicine
  • Publications
  • Real World Evidence
  • Recent Posts
  • Type A Diabetes

Tags

alzheimer's autism cancer Event Fibromyalgia Graft rejection Influenza Kidney Laboratory lung neurological Oncology Professor Jean-Yves BLAY Centre Leon berard Parkinson Parkinson’s precisionmedicine precision medicine publication realworldevidence recent post Recent Posts Research Transplant vaccine

Elara Pharmaceuticals Ltd, The AI DRUG Development Company

  • The Barn Holly Berry House Rough Park,
    Hamstall Ridware, Rugeley, Staffordshire, WS15 3SQ
  • Call Us: +44 20 8040 0302
  • info@elarapharma.com

Menu

  • About Us
  • Our business
  • Technology
  • In The News
  • Contact Us

Subscribe

Keep in touch and subscribe to our latest news

    Elara Pharmaceuticals Ltd © 2024 All Rights Reserved